Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Health Management Center, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong, China.
Br J Hosp Med (Lond). 2024 Sep 30;85(9):1-16. doi: 10.12968/hmed.2024.0326. Epub 2024 Sep 26.
Gastric cancer is a common and life-threatening cancer, which predisposes patients to certain psychological problems. Implementation of both personalized nutrition and acceptance and commitment therapy (ACT) have shown unique advantages in the treatment of cancer patients. This study aims to evaluate the effects of this comprehensive therapy on psychological resilience, quality of life and side effects of chemotherapy in patients with advanced gastric cancer (AGC), yielding findings that can inform the development of holistic and effective treatment methods. The clinical data of 240 AGC patients who underwent chemotherapy in the Fourth Hospital of Hebei Medical University from February 2021 to February 2023 were retrospectively analyzed. After excluding 15 patients who did not meet the inclusion criteria, 225 patients were included in the study. According to the management methods, the patients were divided into three groups: group A receiving routine management (n = 76), group B receiving routine management plus personalized nutrition (n = 75), and group C receiving routine management, personalized nutrition and ACT (n = 74). The psychological resilience, quality of life and side effects of chemotherapy were evaluated in the three groups. There was no difference in the Connor-Davidson resilience scale (CD-RISC) scores and quality of life questionnaire-core 30 (QLQ-C30) scores among the three groups at admission ( > 0.05). After chemotherapy, compared with the group C, the CD-RISC scores of group A and group B were significantly lower ( < 0.001), and the scores of physical function, cancer-related symptoms and overall health in group A and group B were significantly lower ( < 0.001). The incidence of side effects of chemotherapy in group C was 25.68%, which was significantly lower than that in group A and group B ( < 0.05); there was no statistical difference in this regard between group A and group B ( > 0.05), and the same parameter was significantly different between group A and group C ( < 0.05). Personalized nutrition management plus ACT has a significant favorable effect on improving psychological resilience, alleviating the side effects of chemotherapy, and enhancing the quality of life in patients with AGC undergoing chemotherapy.
胃癌是一种常见且危及生命的癌症,使患者易患某些心理问题。个性化营养和接受与承诺疗法(ACT)的实施在癌症患者的治疗中显示出独特的优势。本研究旨在评估这种综合疗法对晚期胃癌(AGC)患者心理弹性、生活质量和化疗副作用的影响,为开发整体有效的治疗方法提供依据。
回顾性分析 2021 年 2 月至 2023 年 2 月在河北医科大学第四医院接受化疗的 240 例 AGC 患者的临床资料。排除不符合纳入标准的 15 例患者后,225 例患者纳入研究。根据管理方法,患者分为三组:常规管理组(A 组,n=76)、常规管理加个性化营养组(B 组,n=75)和常规管理、个性化营养和 ACT 组(C 组,n=74)。三组患者均进行心理韧性、生活质量和化疗副作用评估。
三组患者入院时的康耐得韧性量表(CD-RISC)评分和生活质量问卷核心 30 项(QLQ-C30)评分无差异(>0.05)。化疗后,与 C 组相比,A 组和 B 组的 CD-RISC 评分明显降低(<0.001),A 组和 B 组的生理功能、癌症相关症状和总体健康评分明显降低(<0.001)。C 组化疗副作用发生率为 25.68%,明显低于 A 组和 B 组(<0.05);A 组和 B 组在这方面无统计学差异(>0.05),A 组和 C 组在这方面有显著差异(<0.05)。
个性化营养管理加 ACT 对改善 AGC 化疗患者的心理弹性、减轻化疗副作用、提高生活质量具有显著的有益作用。